相关实验视频
Updated: Jul 27, 2025

06:02
Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model
Published on: July 26, 2011
36.8K
假设:脂肪蛋白颗粒在大脑中被困导致阿尔茨海默氏症
Delphine Boche1, James Ar Nicoll1,2
1Clinical Neurosciences, Clinical and Experimental Science, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
Free neuropathology
|June 7, 2023
概括
在老化过程中,大脑脂蛋白颗粒的运动受损会通过减少神经元胆固醇输送,导致阿尔茨海默病 (AD). 这个假设统一了AD的关键特征,包括粉样β和病理.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 衰老研究研究 衰老研究
背景情况:
- 阿尔茨海默氏病 (AD) 的发病过程涉及复杂的多因素过程.
- 脂蛋白颗粒运输胆固醇,对于神经元功能和突触可塑性至关重要.
- 目前的理解缺乏一个统一的机制,将关键的AD病理联系起来.
研究的目的:
- 为阿尔茨海默氏症 (AD) 病原体提出一个统一的假设.
- 确定衰老大脑中受损的脂蛋白颗粒运动作为AD的核心原因.
- 解释这种主要缺陷如何与AD的主要病理生理特征联系.
主要方法:
- 基于对脂蛋白功能的现有知识和AD病理学的假设生成.
- 对脂蛋白粒子结构,细胞外矩阵相互作用和胆固醇运输的概念分析.
- 解释如何受损的粒子运动导致神经元和质细胞功能障碍.
主要成果:
- 携带胆固醇和溶解粉胺β (Aβ) 的脂蛋白颗粒可以被困在老化大脑的细胞外基质中.
- 这种陷会减少胆固醇到神经元的输送,损害突触可塑性和认知功能.
- 这种假设解释了细胞外Aβ积累,微质激活和神经内tau聚合作为后果.
结论:
- 衰老的大脑中脂蛋白颗粒运动受损被假设为阿尔茨海默病 (AD) 的主要驱动因素.
- 这种机制为主要的AD病理,包括Aβ和tau聚合提供了统一的解释.
- 该假设提供了对临床试验失败的见解,并提出了新的治疗途径.
相关概念视频
Alzheimer's Disease: Overview
536
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
536
Alzheimer's Disease: Treatment
224
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
224
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K
Atherosclerosis I: Introduction
13
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
13
Inflammation
54.0K
Overview
54.0K

